Announced Tue, 31 Mar · 18:25 IST

Krishna Institute of Medical Sciences Limited has informed the Exchange about General Updates

Regulatory & Legal View source PDF

KIMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.6%1-day move
₹622.25
prior close
₹630.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.5+1.0-0.1+0.6+0.6+2.7+6.2+6.2+5.1+4.7+9.8+20.7+33.9
Up moveDown movePending
AI summary

Krishna Institute of Medical Sciences Limited (KIMS) informed exchanges that its subsidiary, SPANV Medisearch Lifesciences Private Limited, has received a favorable order from the Income Tax Department. The department set aside a previous demand notice raised under Section 156 of the Income Tax Act for assessment year 2022-2023. The amount payable on this matter is now Rs. 0 (zero). KIMS had earlier filed an appeal against the original demand with the National Faceless Appeal Centre (NFAC). The order was dated March 29, 2026, and the disclosure was made on March 31, 2026. The company has stated there is no financial, operational, or other impact from this matter.

Likely market impact

This is a positive development for KIMS shareholders as the tax demand against its subsidiary has been fully set aside, removing any potential financial liability. The outcome eliminates uncertainty around the disputed tax amount and has no material impact on the company's operations or finances.